New Jersey S 2179: Requires Medicaid preferred drug lists to provide for coverage of buprenorphine for treatment of chronic pain.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2022-03-07)

State: New Jersey · Session: 220 · Bill: S 2179

Subjects: MEDICAID, PHARMACEUTIC

Sponsors: Madden, Fred H.

View New Jersey S 2179 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.